PDGFRB and breast carcinoma: Although TKIs are only applied to a small number of solid tumors at present and have not shown satisfactory efficacy in the application of breast cancer, existing studies have shown that VEGF and PDGFR are significantly correlated with the prognosis of breast cancer (80, 81), and TKIs have great potential in the treatment of breast cancer.